With the shortages resolved, that lane closes for those specific drugs, and the FDA has published guidance on the wind-down for compounded semaglutide
ADA: Once-Weekly Cagrilintide + Semaglutide Promising in Type 2 Diabetes FRIDAY, June 12, 2026 -- Once-weekly cagrilintide, an amylin receptor agonist, plus semaglutide is efficacious for adults with type 2 diabetes inadequately controlled with diet and exercise, receiving metformin with or without a sodium glucose cotransporter 2 inhibitor (SGLT2i), and using basal insulin, according to three studies published online June 7 in The Lancet Diabetes & Endocrinology and The Lancet to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans
This is important because the deeper layers are where they can have the most impact and make the most significant difference
-Younger pregnant women get them more frequently than older ones
The consistency of the gel ensures that it stays in contact with the skin for an extended period, which may improve absorption rates
The SUSTAIN and STEP trial programs for semaglutide, involving thousands of participants followed for up to two years, did not demonstrate an increased overall cancer risk compared to placebo groups